ZW18787A1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZW18787A1
ZW18787A1 ZW187/87A ZW18787A ZW18787A1 ZW 18787 A1 ZW18787 A1 ZW 18787A1 ZW 187/87 A ZW187/87 A ZW 187/87A ZW 18787 A ZW18787 A ZW 18787A ZW 18787 A1 ZW18787 A1 ZW 18787A1
Authority
ZW
Zimbabwe
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZW187/87A
Other languages
English (en)
Inventor
Rai Behl Charanjit
Unowsky Joel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZW18787A1 publication Critical patent/ZW18787A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZW187/87A 1986-10-07 1987-10-05 Pharmaceutical compositions ZW18787A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91615086A 1986-10-07 1986-10-07

Publications (1)

Publication Number Publication Date
ZW18787A1 true ZW18787A1 (en) 1988-05-25

Family

ID=25436780

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW187/87A ZW18787A1 (en) 1986-10-07 1987-10-05 Pharmaceutical compositions

Country Status (14)

Country Link
EP (1) EP0263493A3 (fi)
JP (1) JPS6396138A (fi)
CN (1) CN87106855A (fi)
AU (1) AU7939487A (fi)
DK (1) DK521487A (fi)
FI (1) FI874382A (fi)
HU (1) HU196903B (fi)
IE (1) IE872667L (fi)
IL (1) IL84099A0 (fi)
MC (1) MC1878A1 (fi)
NO (1) NO874193L (fi)
PT (1) PT85871B (fi)
ZA (1) ZA876930B (fi)
ZW (1) ZW18787A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0643315B2 (ja) * 1988-01-20 1994-06-08 東京田辺製薬株式会社 胆汁酸組成物
DD293494A5 (de) * 1989-03-29 1991-09-05 Fahlberg List Gmbh Magdeburg Verfahren zur herstellung einer galenischen zubereitung mit optimaler bioverfuegbarkeit des wirkstoffs 2-hydroxy-5-methyllauro-phenonoxim (hmlo)
CA2033714A1 (en) * 1990-01-25 1991-07-26 Alberto Ferro Pharmaceutical preparations
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US8093207B2 (en) * 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products
EP2364161B1 (en) * 2008-11-26 2020-03-11 Satiogen Pharmaceuticals, Inc. Compositions containing satiogens and methods of use
US9339480B2 (en) 2008-11-26 2016-05-17 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of obesity and diabetes
WO2011150286A2 (en) 2010-05-26 2011-12-01 Satiogen Pharmaceuticals,Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
CN104023727B (zh) 2011-10-28 2017-04-05 鲁美纳医药公司 用于治疗小儿胆汁淤积性肝病的胆汁酸再循环抑制剂
CN105617353A (zh) * 2016-01-04 2016-06-01 李志海 一种黏菌素口服给药组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562007A (en) * 1978-11-02 1980-05-10 Fujisawa Pharmaceut Co Ltd Preparation for rectal administration
JPS57158719A (en) * 1981-03-24 1982-09-30 Fujisawa Pharmaceut Co Ltd Rectal administration pharmaceutical
US4760059A (en) * 1985-08-05 1988-07-26 Hoffmann-La Roche Inc. Rectal dosage form

Also Published As

Publication number Publication date
EP0263493A3 (de) 1989-06-14
FI874382A0 (fi) 1987-10-06
HUT45395A (en) 1988-07-28
IE872667L (en) 1988-04-07
NO874193L (no) 1988-04-08
JPS6396138A (ja) 1988-04-27
HU196903B (en) 1989-02-28
DK521487D0 (da) 1987-10-05
FI874382A (fi) 1988-04-08
IL84099A0 (en) 1988-03-31
PT85871A (en) 1987-11-01
NO874193D0 (no) 1987-10-06
EP0263493A2 (de) 1988-04-13
CN87106855A (zh) 1988-04-20
DK521487A (da) 1988-04-08
ZA876930B (en) 1988-05-25
MC1878A1 (fr) 1989-01-24
PT85871B (en) 1990-01-17
AU7939487A (en) 1988-04-14

Similar Documents

Publication Publication Date Title
GB2196964B (en) Pharmaceutical compositions
GB8716301D0 (en) Pharmaceutical compositions
GB8723121D0 (en) Pharmaceutical compositions
GB8717582D0 (en) Pharmaceutical compositions
GB8714625D0 (en) Pharmaceutical compositions
GB8708587D0 (en) Pharmaceutical compositions
GB8717581D0 (en) Pharmaceutical compositions
GB8618259D0 (en) Pharmaceutical compositions
GB2191696B (en) Pharmaceutical compositions
GB2190838B (en) Pharmaceutical compositions
PH25390A (en) Pharmaceutical compositions
GB8723120D0 (en) Pharmaceutical compositions
ZW18787A1 (en) Pharmaceutical compositions
GB8723118D0 (en) Pharmaceutical compositions
GB2188235B (en) Pharmaceutical compositions
GR871999B (en) Pharmaceutical compositions
GB8620073D0 (en) Pharmaceutical compositions
GB8621756D0 (en) Pharmaceutical compositions
ZA873841B (en) Pharmaceutical compositions
GB8615041D0 (en) Pharmaceutical compositions
GB8611830D0 (en) Pharmaceutical compositions
GB8612806D0 (en) Pharmaceutical compositions
GB8630932D0 (en) Pharmaceutical compositions
GB8628476D0 (en) Pharmaceutical compositions
GB8626217D0 (en) Pharmaceutical compositions